---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-001977"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-29T00:04:10.284441+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics enters 126-month lease for ~47,300 sq ft lab/office space in San Diego

## Summary
- Lease for 47,300 sq ft at 10955 Vista Sorrento Pkwy, San Diego; commencement July 1, 2022.
- Base rent $271,952/month first year, with 6 months abated; 3% annual escalations thereafter.
- Tenant improvement allowance of ~$10.64 million from landlord.
- Letter of credit requirement of $815,856, reducible by 50% after 54 months.
- Term of 126 months; space for office, lab, vivarium, and R&D use.

## SEC filing metadata
- accession: 0000950170-21-001977
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000095017021001977/0000950170-21-001977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000095017021001977/janx-20211001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-001977
- JSON: https://secwatch.observer/filing/0000950170-21-001977.json
- Plain text: https://secwatch.observer/filing/0000950170-21-001977.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.